Jane Salik News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jane salik. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jane Salik Today - Breaking & Trending Today

PolyPeptide Group plans IPO and listing on the Swiss Stock Exchange

PolyPeptide Group plans IPO and listing on the Swiss Stock Exchange
EQS Group-News: PolyPeptide Group
/ Key word(s): IPO
12.04.2021 / 07:00
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.
FOR RELEASE IN SWITZERLAND - THIS IS A RESTRICTED COMMUNICATION AND YOU MUST NOT FORWARD IT OR ITS CONTENTS TO ANY PERSON TO WHOM FORWARDING THIS COMMUNICATION IS PROHIBITED BY THE LEGENDS CONTAINED HEREIN.
PolyPeptide Group plans IPO and listing on the Swiss Stock Exchange ....

Braine Lalleud , Waals Gewest , United States , District Of Columbia , United Kingdom , Erik Schropp , Philippe Weber , Jan Fuhr Miller , Peter Wilden , Jane Salik , Morgan Stanley , Head Of Investor Relations Corporate Communications , Lemongrass Communications , Contract Development Manufacturing Organization , Danske Bank , European Union Withdrawal , European Union , Polypeptide Group , Commission Delegated Directive , Polypetide Group , Committee Of Polypeptide Group , Rothschild Co , Swiss Stock Exchange , Credit Suisse , Financial Services , Swiss Financial Services ,

BioSpace Movers & Shakers, Feb. 19

Published: Feb 19, 2021
By Alex Keown
PICI – Bristol Myers Squibb veteran Ute Dugan was named Senior Vice President of Clinical Research at the Parker Institute for Cancer Immunotherapy (PICI). She will oversee PICI’s clinical development, regulatory affairs and translational medicine efforts, with a focus on overcoming immunotherapy resistance and advancing novel breakthrough treatment combinations. At BMS, she was head of Worldwide Oncology External Medical Affairs, where she created research collaboration models to advance immune-oncology treatments together with partners in academia, professional societies and non-profit organizations. Dugan originally joined BMS as executive director of Global Clinical Research during the formation of the development teams for the pioneering I-O medicines ipilimumab and nivolumab. Before that, her career included stints at Roche/Genentech and Aventis. ....

United States , United Kingdom , John Hohneker , Tamraj Adams , Paul Kidwell , Ute Dugan , Nawal Ouzrem , Kristi Clark , Joe Johntson , Bridget Okeeffe , Natalie Holles , Bristol Myers Squibb , Jane Salik , Barry Blake , Charles Albright , Alan Boyd , Richard Kim , Don Ross , Burroughs Wellcome , Evelo Biosciences , Matteo Levisetti , Aeglea Biotherapeutics , Gaurav Dave , Wendyk Chung , Los Angeles , Davidp Dimmock ,

PolyPeptide Group names new CEO before likely Swiss IPO during 2021

Read more about PolyPeptide Group names new CEO before likely Swiss IPO during 2021 on Business Standard. Raymond De Vre, a Belgian who previously worked at Indian contract manufacturer Dr. Reddy s Laboratories as global head of biologics, will join PolyPeptide Group as CEO-elect in April ....

United States , John Miller , Jane Salik , Polypeptide Group , Novavax Inc , Chief Executive Officer , ஒன்றுபட்டது மாநிலங்களில் , ஜான் மில்லர் , ஜேன் சலிக் , தலைமை நிர்வாகி அதிகாரி ,